These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 15886040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
    Young SP, Zhang H, Corzo D, Thurberg BL, Bali D, Kishnani PS, Millington DS.
    Genet Med; 2009 Jul; 11(7):536-41. PubMed ID: 19521244
    [Abstract] [Full Text] [Related]

  • 3. Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease.
    An Y, Young SP, Hillman SL, Van Hove JL, Chen YT, Millington DS.
    Anal Biochem; 2000 Dec 01; 287(1):136-43. PubMed ID: 11078593
    [Abstract] [Full Text] [Related]

  • 4. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP, Piraud M, Goldstein JL, Zhang H, Rehder C, Laforet P, Kishnani PS, Millington DS, Bashir MR, Bali DS.
    Am J Med Genet C Semin Med Genet; 2012 Feb 15; 160C(1):50-8. PubMed ID: 22252961
    [Abstract] [Full Text] [Related]

  • 5. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA.
    Acta Neurol Belg; 2006 Jun 15; 106(2):82-6. PubMed ID: 16898258
    [Abstract] [Full Text] [Related]

  • 6. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice.
    Zhu Y, Li X, McVie-Wylie A, Jiang C, Thurberg BL, Raben N, Mattaliano RJ, Cheng SH.
    Biochem J; 2005 Aug 01; 389(Pt 3):619-28. PubMed ID: 15839836
    [Abstract] [Full Text] [Related]

  • 7. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N, Fukuda T, Gilbert AL, de Jong D, Thurberg BL, Mattaliano RJ, Meikle P, Hopwood JJ, Nagashima K, Nagaraju K, Plotz PH.
    Mol Ther; 2005 Jan 01; 11(1):48-56. PubMed ID: 15585405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyaluronidase increases the biodistribution of acid alpha-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy.
    Matalon R, Surendran S, Campbell GA, Michals-Matalon K, Tyring SK, Grady J, Cheng S, Kaye E.
    Biochem Biophys Res Commun; 2006 Nov 24; 350(3):783-7. PubMed ID: 17027913
    [Abstract] [Full Text] [Related]

  • 10. Quantitative computed tomography for enzyme replacement therapy in Pompe disease.
    Yonee C, Toyoshima M, Young SP, Maruyama S, Higuchi I, Narita A, Maegaki Y, Nanba E, Ohno K, Kawano Y.
    Brain Dev; 2012 Nov 24; 34(10):834-9. PubMed ID: 22521436
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial.
    Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Görlinger K, Wallot M, Richards S, Voit T.
    Neuromuscul Disord; 2005 Jan 24; 15(1):24-31. PubMed ID: 15639117
    [Abstract] [Full Text] [Related]

  • 12. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
    Martiniuk F, Chen A, Donnabella V, Arvanitopoulos E, Slonim AE, Raben N, Plotz P, Rom WN.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):917-23. PubMed ID: 11027569
    [Abstract] [Full Text] [Related]

  • 13. Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.
    Kikuchi T, Yang HW, Pennybacker M, Ichihara N, Mizutani M, Van Hove JL, Chen YT.
    J Clin Invest; 1998 Feb 15; 101(4):827-33. PubMed ID: 9466978
    [Abstract] [Full Text] [Related]

  • 14. Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease.
    Hunley TE, Corzo D, Dudek M, Kishnani P, Amalfitano A, Chen YT, Richards SM, Phillips JA, Fogo AB, Tiller GE.
    Pediatrics; 2004 Oct 15; 114(4):e532-5. PubMed ID: 15466083
    [Abstract] [Full Text] [Related]

  • 15. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
    Wang LY, Ross AK, Li JS, Dearmey SM, Mackey JF, Worden M, Corzo D, Morgan C, Kishnani PS.
    Paediatr Anaesth; 2007 Aug 15; 17(8):738-48. PubMed ID: 17596219
    [Abstract] [Full Text] [Related]

  • 16. [Tetra-saccharide glucose as a diagnostic biomarker for Pompe disease: a study with 35 patients].
    Bobillo Lobato J, Durán Parejo P, Tejero Díez P, Jiménez Jiménez LM.
    Med Clin (Barc); 2013 Aug 04; 141(3):106-10. PubMed ID: 23756115
    [Abstract] [Full Text] [Related]

  • 17. Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry.
    Young SP, Stevens RD, An Y, Chen YT, Millington DS.
    Anal Biochem; 2003 May 15; 316(2):175-80. PubMed ID: 12711338
    [Abstract] [Full Text] [Related]

  • 18. Monitoring cardiac function by B-type natriuretic peptide (BNP) in patients with infantile Pompe's disease treated with recombinant alpha-glucosidase.
    Hahn A, Schmidt D, Hagel KJ, Neubauer BA, Katz N.
    Clin Lab; 2006 May 15; 52(11-12):615-9. PubMed ID: 17175893
    [Abstract] [Full Text] [Related]

  • 19. Gingival overgrowth in Pompe disease: a case report.
    de Gijt JP, van Capelle CI, Oosterhuis JW, van der Ploeg AT, van der Wal KG.
    J Oral Maxillofac Surg; 2011 Aug 15; 69(8):2186-90. PubMed ID: 21783002
    [Abstract] [Full Text] [Related]

  • 20. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.
    Douillard-Guilloux G, Richard E, Batista L, Caillaud C.
    J Gene Med; 2009 Apr 15; 11(4):279-87. PubMed ID: 19263466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.